Overview of the dysfunctional metabolic pathways in pulmonary vascular cell types implicated in the development of pulmonary hypertension. Overview of.

Slides:



Advertisements
Similar presentations
1 Chapter 24 Calcium Copyright © 2012, American Society for Neurochemistry. Published by Elsevier Inc. All rights reserved.
Advertisements

QSAR features for inhibitors of mitochondrial bioenergetics. Anatoly A. Starkov.
Metabolism and Cancer Bob Harris D-3034 Roudebush VA Medical Center Fall 2010.
1 Lecture 6B – outline Mitochondrial function (e.g. hepatocytes) 1) citric acid cycle as an energy source a) pyruvate or  -ketoglutarate dehydrogenase.
TCA Cycle.
Coordination of Intermediary Metabolism. ATP Homeostasis Energy Consumption (adult woman/day) – kJ (>200 mol ATP) –Vigorous exercise: 100x rate.
Citric acid cycle and respiratory chain Pavla Balínová.
Mitochondrial Retrograde Signaling Mediated by UCP2 Inhibits Cancer Cell Proliferation and Tumorigenesis 석사 1 학기 Tran Phuong Thao.
Date of download: 7/2/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Adrenergic-Fatty Acid Load in Heart Failure J.
Tricarboxylic Acid Cycle TCA cycle
Cristoforo Grasso, Gerrit Jansen, Elisa Giovannetti 
Metabolism 1: Catabolism
Obstacles in Renal Regenerative Medicine: Metabolic and Epigenetic Parallels Between Cellular Reprogramming and Kidney Cancer Oncogenesis  Zsuzsanna Lichner,
Mechanisms of diabetic neuropathy.
Figure 3 Metabolism in homeostatic chondrocytes
Oxidative stress and hypoxia in normal and leukemic stem cells
Valerie D. Myers et al. BTS 2018;3:
Sirtuins and the Metabolic Hurdles in Cancer
Figure 2 Candidate signalling pathways of irisin in myocytess
The Metabolic Basis of Pulmonary Arterial Hypertension
Nat. Rev. Nephrol. doi: /nrneph
Figure 3 Metabolic configurations of M1 and M2 macrophages
Nat. Rev. Nephrol. doi: /nrneph
Figure 5 Regulation of inflammation by metabolites
Figure 4 Altered metabolism in chondrocytes in osteoarthritis
NASH: a mitochondrial disease
Transcriptional inflammatory response to hypoxia and cellular necrosis
Muscle Fatigue from Losing Your PHD
Coming up for air: HIF-1 and mitochondrial oxygen consumption
Patrick S. Ward, Craig B. Thompson  Cancer Cell 
Pyruvate Dehydrogenase
Metformin: From Mechanisms of Action to Therapies
Understanding the Intersections between Metabolism and Cancer Biology
Figure 1 Involvement of pVHL in cellular physiology and RCC
Metabolic reprogramming in the hypoxic microenvironmentThis figure shows the metabolic processes that are upregulated in response to hypoxia and the therapeutic.
Key pathways involved in the pathogenesis of pulmonary arterial hypertension: a) endothelin (ET) pathway; b) nitric oxide pathway; and c) prostacyclin.
Tumor Cell Metabolism: Cancer's Achilles' Heel
Role of Endothelial Cell Metabolism in Vessel Sprouting
Mitochondria: In Sickness and in Health
Cancer Metabolism: Is Glutamine Sweeter than Glucose?
Figure 1 NETosis pathways and potential therapeutic targets
Hypoxia-Inducible Factors in Physiology and Medicine
Conserved Metabolic Regulatory Functions of Sirtuins
Mitochondrial pharmacology
Gabriela Andrejeva, Jeffrey C. Rathmell  Cell Metabolism 
Pierre Theurey, Jennifer Rieusset  Trends in Endocrinology & Metabolism 
Diagnostic applications of metabolic dysregulation in pulmonary hypertension. Diagnostic applications of metabolic dysregulation in pulmonary hypertension.
The mechanisms by which mitochondrial dysfunction in chronic obstructive pulmonary disease (COPD) lead to increased oxidative stress and inflammation,
Glutamine has pleiotropic role of positively regulating respiration and maintaining redox balance selectively in high‐invasive ovarian cancer (OVCA) cells.
Organelle crosstalk in the kidney
Volume 7, Issue 1, Pages (January 2008)
Glycolytic and mitochondrial ATP production, the electron transport chain, and oxidative phosphorylation Glycolytic and mitochondrial ATP production, the.
Volume 11, Issue 5, Pages (November 2012)
Volume 3, Issue 1, Pages 9-13 (January 2006)
Muscle Fatigue from Losing Your PHD
Established and putative mediators and pathways involved in the pathogenesis of pulmonary arterial hypertension. Established and putative mediators and.
Volume 77, Issue 10, Pages (May 2010)
Model for the regulation of insulin secretion in the β-cell stimulated by glucose and amino acids. Model for the regulation of insulin secretion in the.
Pulmonary arterial hypertension specific medication use at enrolment among previously diagnosed patients. 184 (7%) of patients were not on a prostaglandin,
Metformin: From Mechanisms of Action to Therapies
Figure 1 Thyroid hormone effects on hepatic lipid metabolism
The cyctoprotective endoplasmic reticulum (ER) stress mechanism [32].
Compounds acting on pathogenic pathways of pulmonary arterial hypertension. Compounds acting on pathogenic pathways of pulmonary arterial hypertension.
Darshi et al. Am J Nephrol 2016;44: (DOI: / )
Nutrient Sensing, Metabolism, and Cell Growth Control
GADD34 is a master regulator of the integrated stress response.
Novel targets for mitochondrial medicine
Main metabolic pathways deregulated in cancers and corresponding targeting drugs. Main metabolic pathways deregulated in cancers and corresponding targeting.
Volume 7, Issue 1, Pages (January 2008)
Fig. 1. Consequences of diabetes-induced alterations in substrate metabolism and sources of increased ROS in DC. Increased FA uptake results in accumulation.
Presentation transcript:

Overview of the dysfunctional metabolic pathways in pulmonary vascular cell types implicated in the development of pulmonary hypertension. Overview of the dysfunctional metabolic pathways in pulmonary vascular cell types implicated in the development of pulmonary hypertension. KG: ketoglutarate; ΔΨm: mitochondrial membrane potential; AMPK: adenosine monophosphate-activated protein kinase; ATF: activating transcription factor; Ca2+: calcium; DRP: dynamin-related protein; ER: endoplasmic reticulum; ETC: electron transport chain; FAO: fatty acid oxidation; Fe: iron; S: sulfur; Gln: glutamine; GLS1: glutaminase; Glu: glutamate; HIF: hypoxia-inducible factor; IDH: isocitrate dehydrogenase; Irp: iron-regulatory protein; ISCU: iron-sulfur cluster assembly protein; Kv1.2: voltage-dependent potassium channel 1.2; MCUC: mitochondrial calcium uniporter complex; miR-210: micro-RNA 210; Mit: mitochondria; MPTP: mitochondrial permeability transition pore; Nogo-B: neurite outgrowth inhibitor-B; O2: oxygen: PDH: pyruvate dehydrogenase; PDK: pyruvate dehydrogenase kinase; PFK: phosphofructokinase; PGC: proliferator-activated receptor-y coactivator; PHD: prolyl hydroxlase; ROS: reactive oxygen species; SERCA: sarco-/endoplasmic reticulum calcium-ATPase; TAZ: transcription coactivator with a PDZ-binding motif; TCA: tricarboxylic acid; UCP: uncoupling protein; YAP: yes-associated protein. Stephen Y. Chan, and Lewis J. Rubin Eur Respir Rev 2017;26:170094 ©2017 by European Respiratory Society